Global Aesthetic Dermatology Market to 2024
Aesthetic dermatology is a subspecialty of medicine intended to enhance one’s appearance. The pursuit of physical beauty has become big business in developed markets and fast catching up among affluent and wealthy individuals in emerging markets. People seem to be more conscious of their looks than ever before world over.
The procedures adopted in aesthetic dermatology can split as either invasive or non-invasive. Key procedures relevant to the aesthetic dermatology market are botulinum toxin (non-invasive), dermal fillers (non-invasive), breast augmentation (invasive) and lipoplasty (invasive).
Approximately 6 million aesthetic procedures are conducted annually in the U.S. alone. Korea is ranked first in the world, in terms of the number of plastic surgeons per capita and the proportion of population undergoing cosmetic procedures. China is rising fast in aesthetic procedures driven by growing demand from younger generation. According to the China Association of Plastics and Aesthetics (CAPA), more than 7 million people, mostly young women, had cosmetic surgery in 2014.
Request For TOC : http://www.optimainsights.org/request-toc/global-aesthetic-dermatology-market-to-2024
Global Aesthetic Dermatology Market – Geographic Sales Distribution
“Large target market in aesthetic dermatology”
The addressable market in aesthetic dermatology is large. For example in China, there are over 330m women aged between 20 and 50. Different age groups have different needs varying from skin rejuvenation and anti-aging, to face contouring. In the U.S, people over the age of 35 accounts for 80% of non-surgical procedures. This group of people gives lot of importance to their appearances and has money to spend on themselves. Moreover, the market entries from a number of Korean and Chinese companies that offer strong price competitiveness have resulted in increased demand. and declining prices of aesthetic procedures.
“Allergan, Valeant, Ipsen, Merz are some of the key players in aesthetic dermatology market"
Allergan’s Botox is the leading franchise in the aesthetic dermatology market. The market for botulinum toxin worldwide is continually expanding with the U.S. market accounting for approximately 60% in sales. Botox competes with Ipsen’s Dysport and Merz’s Xeomin in other countries.
Allergan also has strong presence in the dermal filler space through its acquisition of Inamed in 2005 and gained access to Cosmoderm and Zyderm product lines.
Valeant through acquisition of Medicis is a leader in dermal fillers with its hyaluronic acid (HA) filler product line led by Restylane. HA dermal filler injections have become quite popular due to their convenience and favorable safety profile.
In recent years, J&J has introduced Evolence, the HA-based dermal filler similar to Valeant’s Restylane and Allergan’s Juvederm.
From an international competitive scenario, in recent times, Bloomage and Shanghai Haohai (both listed in HK exchange) have moved into the aestehetic dermatology space by launching HA dermal filler products.
In the Korean market, the growing beauty treatment market is benefiting Medytox, with its well-balanced product portfolio, and LG Life Sciences that offer an edge in Hyaluronic Acid (HA) dermal fillers.
“Reimbursement coverage and Payer Insights”
Since aesthetic dermatology procedures are mostly elective, the market is not reimbursement dependent. While this is a disadvantage in a down economy, companies introducing new products in the segment are able to escape the hassle of securing reimbursement for new products, which are often costly and time-consuming process. Plastic surgeon are more than willing to adopt new products quickly after launch, which is not always the case in other areas of healthcare.
“Favorable outlook of the sector”
The long-term fundamentals of the aesthetic dermatology market look favorable. Companies such as Valeant that have introduced new products focused on the aesthetic marketplace during the past several years have significantly benefited from the favorable dynamics of this unique market. Allergan’s $2.1bn acquisition of Kythera in April 2015 brought in to its fold the game-changing Kybella treatment for double-chin while strengthening its facial aesthetics portfolio.
Body contouring and fat-based procedures continue to be a focus of the industry. Additionally, home therapies and consumer-based initiatives are still a major focus in the aesthetic dermatology space. The next generation products for skin resurfacing, skin tightening, and tattoo removal will continue to advance the industry’s core businesses forward.
Optima Insights is an innovative research and insights driven enterprise committed to offer actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content holds the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them take better business decisions towards attaining market leadership.
Manager International Marketing
1 MMC, Road, Chennai. Pin - 600060,
Tamil Nadu, I N D I A
Phone: +91 966 6620 365
Whatsapp: +91 966 6620 365
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Aesthetic Dermatology Market to 2024 here
News-ID: 816659 • Views: 604
More Releases from Optima insights Pvt Ltd
Endometriosis Treatment Market is Expected to Reach $3.43 bn by 2027
The Endometriosis Treatment Market was valued at US $2.64 billion in the year 2019 and is estimated to reach US $3.43 billion by 2027, at a CAGR of 3.36%. The growth of tissue outside the uterus similar to lining of uterus (endometrium) refers to Endometriosis. Areas of endometrial tissue growth often occur in ovaries, fallopian tubes, peritoneum and outer surfaces of bladder, uterus, intestines, and rectum and rarely spread beyond pelvic
Inflammatory Bowel Disease (IBD) Treatment Market is Expected to Reach $15.5 bn …
The Inflammatory Bowel Disease (IBD) treatment market share was US$ 11.38 Bn in the year 2018. The market is anticipated to grow at a rate of 3.94%, through the forecast period to reach US$ 15.5 Bn by the year 2027. Inflammatory Bowel Disease (IBD) usually denotes disorders characterized by the inflammation in the digestive system. Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome are two different disorders that are often confused
Polycystic Ovarian Syndrome (PCOS) Treatment Market is Expected to Reach $5.59 b …
The Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US $3.74 billion in the year 2019 and is estimated to reach US $5.59 billion by 2027, at a CAGR of 5.18%. Polycystic Ovarian Syndrome (PCOS), also referred to as Stein-Leventhal syndrome is a hormonal disorder characterized by enlarged ovaries and formation of numerous small cysts (fluid-filled sacs) on the outer edges of the ovaries. Symptoms of PCOS include irregular periods,
Veterinary Vaccines Market is Expected to Reach $13.51 bn by 2027
The Veterinary Vaccines Market was valued at US $7.91 billion in the year 2018 and is estimated to reach US $13.51 billion by 2027, at a CAGR of 6.13%. Generally, vaccines are effective in preventing infectious diseases. Veterinary vaccines especially reduce the burden of the disease in animals and also helps in preventing several zoonotic diseases also. There are four types of veterinary vaccines available depending on preparation type, they are
More Releases for Aesthetic
International Meeting on Aesthetic Medicine
Conference Series LLC Ltd invites all the participants from all over the world to attend International Meeting on Aesthetic Medicine during November 12th-13th, 2018 in Osaka, Japan. It includes Keynote Presentations, Poster Presentations, E-poster, Oral talks, Workshop, and Exhibitions. Aesthetic Medicine and Dermatology is the best successfully organized conference since many years. It is the top most conference which unites eminent persons in the field of Aesthetic Medicine, Dermatology, Cosmetology, Plastic
Does Vaser Lipo Gives Aesthetic Pleasing Results
How Does Vaser Lipo Works? The fatty layers are targeted for removing the fat cells with gentle ease. The surgery is administrated under local anesthesia; the targeted areas are injected with tumescent fluid for liquefying the fat deposits. A hollow probe or cannula which distributes high-ultrasound energy for emulsifying fat cells which makes easy for aspiration of those fats. The surrounding fats are kept unharmed, undamaged and it also allows for
Aesthetic Devices-Medical Devices Pipeline Assessment 2017
ReportsWeb.com published “Aesthetic Devices-Medical Devices Pipeline Assessment 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's Medical Devices sector report, "Aesthetic Devices-Medical Devices Pipeline Assessment, 2017" provides an overview of Aesthetic Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at
Central Sutton Aesthetic Dentistry
Central Sutton Aesthetic Dentistry are experts at creating a calm and welcoming environment, a vital factor in any dental clinic looking to provide the best possible experience for their patients. The dentist in Sutton Coldfield, situated only a three-minute walk from Gracechurch Shopping Centre, has been established there for over 30 years. The practice has become extremely well-versed in providing only the highest standards of dental care. This experience combined
Medical Aesthetic Devices Industry Analysis by Segments
Middle East and North Africa Medical Aesthetic Devices Market: Snapshot The market for medical aesthetic devices in the Middle East and North Africa has witnessed substantial growth since its inception. In the recent times, there has been a noticeable rise in adoption of aesthetic procedure among consumers in these regions, which has reflected greatly on this market. The introduction of new aesthetics products and the technological advancement in current offerings, improving
Medical Aesthetic Devices Market Research Report 2024
Medical Aesthetic Devices Market: Snapshot Expanding at a healthy 9.9% CAGR from 2016 to 2024, the medical aesthetic devices market is poised to amount to a value of US$15.1 bn by 2024. The opportunity in the market was pegged at US$6.5 bn in 2015. This signifies that despite the small share aesthetics holds in the overall medical devices industry, the market holds immense scope for growth. A rapidly expanding pool